Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapy of Sjögren's syndrome.

Literature DB >> 11455852

Therapy of Sjögren's syndrome.

N M Moutsopoulos¹, H M Moutsopoulos.

Abstract

Entities: Disease

Mesh：

Year: 2001 PMID： 11455852 DOI： 10.1007/s002810100070

Source DB: PubMed Journal: Springer Semin Immunopathol ISSN： 0344-4325

× No keyword cloud information.

31 in total

1. Increased bronchial responsiveness in primary Sjögren's syndrome. A sign of tracheobronchial involvement.

Authors: R La Corte; A Potena; G Bajocchi; L Fabbri; F Trotta
Journal: Clin Exp Rheumatol Date: 1991 Mar-Apr Impact factor: 4.473

Review 2. Preventing dental caries: current and prospective strategies.

Authors: E Newbrun
Journal: J Am Dent Assoc Date: 1992-05 Impact factor: 3.634

Review 3. Preventing dental caries: breaking the chain of transmission.

Authors: E Newbrun
Journal: J Am Dent Assoc Date: 1992-06 Impact factor: 3.634

Review 4. The uncertain role of immunosuppressive agents in Sjögren's syndrome.

Authors: G Linardaki; H M Moutsopoulos
Journal: Cleve Clin J Med Date: 1997 Nov-Dec Impact factor: 2.321

Review 5. Sjögren's syndrome therapy: future directions.

Authors: H M Moutsopoulos
Journal: J Rheumatol Suppl Date: 1997-09

6. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

Authors: J Zulman; R Jaffe; N Talal
Journal: N Engl J Med Date: 1978-11-30 Impact factor: 91.245

7. Liver involvement in primary Sjögren's syndrome.

Authors: F N Skopouli; C Barbatis; H M Moutsopoulos
Journal: Br J Rheumatol Date: 1994-08

Review 8. Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

Authors: W A van der Reijden; A Vissink; E C Veerman; A V Amerongen
Journal: Ann Rheum Dis Date: 1999-08 Impact factor: 19.103

9. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Authors: D T Boumpas; H A Austin; E M Vaughn; J H Klippel; A D Steinberg; C H Yarboro; J E Balow
Journal: Lancet Date: 1992-09-26 Impact factor: 79.321

10. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.

Authors: J D Nelson; R L Farris
Journal: Arch Ophthalmol Date: 1988-04

5 in total

Therapy of Sjögren's syndrome.

1. Increased bronchial responsiveness in primary Sjögren's syndrome. A sign of tracheobronchial involvement.

Review 2. Preventing dental caries: current and prospective strategies.

Review 3. Preventing dental caries: breaking the chain of transmission.

Review 4. The uncertain role of immunosuppressive agents in Sjögren's syndrome.

Review 5. Sjögren's syndrome therapy: future directions.

6. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

7. Liver involvement in primary Sjögren's syndrome.

Review 8. Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

9. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

10. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.

Review 1. Conventional therapy of Sjogren's syndrome.

2. Immunological consequences of thalidomide treatment in Sjögren's syndrome.

3. Treating Sjögren's Syndrome: Insights for the Clinician.

Review 4. Recent advances in the management of ocular complications of Sjögren's syndrome.

Review 5. Oral and Maxillo-Facial Manifestations of Systemic Diseases: An Overview.